ENCINITAS, CALIF., November 4, 2023 – Kiora Pharmaceuticals (NASDAQ: KPRX) today announced topline results of a Phase I/II clinical trial demonstrating proof-of-concept that KIO-301, the company’s first-in-class small molecule, has the potential to meaningfully improve vision ...

DALLAS, TX -- November 3rd, 2023 -- Independence Contract Drilling, Inc (NYSE: ICD): Stonegate Capital Partners updates coverage on Independence Contract Drilling, Inc.  COMPANY UPDATES ICD continues to position itself for long-term growth while maintaining impressive operati...

SALT LAKE CITY – November 3, 2023 - BioUtah today announced the winners of its 2023 Life Sciences Awards. Five awards will be presented during the 2023 Mayer Brown Utah Life Sciences Summit Nov. 9 at the Salt Palace, in Salt Lake City. BioUtah’s annual awards recognize leaders...

INDIANAPOLIS, IN - Sarson Funds, a boutique manager in blockchain and trusted advisor to professional investors, web3 founders, and top 100 crypto projects, announced new service providers in the firm's recently launched stablecoin issuance business line. For Sarson Funds' rec...

DALLAS, TX -- October 31st, 2023 --  Isabella Bank Corporation (OTCQX: ISBA): Stonegate Capital Partners updates their coverage on Isabella Bank Corporation (OTCQX: ISBA). Business Overview Isabella Bank Corporation (the Company, the Bank, or Isabella) operates as a holding c...

DALLAS, TX -- October 31st, 2023 --  NCS Multistage Holdings, Inc. (NASDAQ: NCSM): Stonegate Capital Partners updates their coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM).  BUSINESS OVERVIEW NCS Multistage Holdings, Inc. (“NCS”, “NCSM”, “NCS Multistage”, or “the Com...

Salt Lake City - October 27, 2023 - BioUtah, Utah’s trade association serving the state’s life sciences community, announced today Myles Greenberg, MD, MBA, CEO of Alucent Biomedical, as the new board chair, effective January 2024.  Dr. Greenberg, an experienced life sciences ...

San Diego, CA – October 31, 2023 – Okogen, an ophthalmic biotechnology company, today announced the initiation of a Phase IIb clinical trial evaluating OKG-0303 for Acute Infectious Conjunctivitis (“Pink Eye”) to be conducted in India. Additionally, as part of the corporate re...

DALLAS, TX -- October 30th, 2023 -- Alliance Resource Partners, L.P. (NASDAQ: ARLP): Stonegate Capital Partners updates coverage on Alliance Resource Partners, L.P.  ARLP Releases 3Q23 Earnings, Maintaining Momentum ARLP reported solid 3Q23 results that continued the trend of...

DALLAS, TX -- October 30th, 2023 --  Civeo Corporation (NYSE: CVEO): Stonegate Capital Partners updates their coverage on Civeo Corporation. Business Overview Civeo Corporation provides workforce accommodations and hospitality services in the United States, Canada, and Austra...